The Valley Hospital, Inc.

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Lung cancer1 trial
• Mantle cell lymphoma1 trial
• Melanoma1 trial

Phase

• Phase 33 trials

Status

• Recruiting3 trials

Lead sponsor

• BeOne Medicines1 trial
• Eli Lilly and Company1 trial
• Regeneron Pharmaceuticals1 trial

Running trials

• Recruiting

  A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)

  NCT06742996· Phase 3· BeOne Medicines· Source

  Contact: Study Director

• Recruiting

  A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

  NCT06246916· Phase 3· Regeneron Pharmaceuticals· Source

  Contact: Clinical Trials Administrator

• Recruiting

  A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  NCT06119581· Phase 3· Eli Lilly and Company· Source

  Contact: Eli Kirshner (principal investigator)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer1 recruiting
• Mantle cell lymphoma1 recruiting
• Melanoma1 recruiting